KDM1A and breast cancer: Not only is the overexpression of LSD-1 linked to more aggressive subtypes of breast cancer, but it is also associated with poorer outcomes in these subtypes of breast cancer, such as shorter recurrence-free survival and higher hazard ratios for recurrence [97].